An association between liraglutide treatment and reduction in excessive daytime sleepiness in obese subjects with type 2 diabetes

BACKGROUND: The main purpose of the present study is to evaluate whether treatment with long-acting human glucagon-like peptide-1 liraglutide was associated with an improvement of excessive daytime sleepiness (EDS) in obese subjects with type-2 diabetes. METHODS: This single-centre retrospective stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Gomez-Peralta, Fernando, Abreu, Cristina, Castro, Jose Carlos, Alcarria, Elvira, Cruz-Bravo, Margarita, Garcia-Llorente, Maria Jesús, Albornos, Cristina, Moreno, Concepción, Cepeda, María, Almodóvar, Francisca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669657/
https://www.ncbi.nlm.nih.gov/pubmed/26637348
http://dx.doi.org/10.1186/s12902-015-0074-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669657/
https://www.ncbi.nlm.nih.gov/pubmed/26637348
http://dx.doi.org/10.1186/s12902-015-0074-6

Ejemplares similares